ITEMS IN AFP WITH KEYWORD:
A single-question alcohol use screen and the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C) can be used to detect unhealthy alcohol use and alcohol use disorder. Their performance is similar between sexes and across races.
Jul 15, 2016 Issue
Pharmacotherapy for Adults with Alcohol Use Disorder [Implementing AHRQ Effective Health Care Reviews]
What are the potential benefits and adverse effects of medications used to treat alcohol use disorder (AUD) in adult outpatients?
Although excessive alcohol use is the third leading cause of preventable death in the United States, many patients do not receive treatment. Three medications are approved for treating alcohol use disorder, and several other medications may also be helpful for off-label use.
Jun 15, 2014 Issue
Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse [Putting Prevention into Practice]
A 22-year-old man presents for a routine physical examination. While you are taking his history, he states that he “goes out drinking” every weekend with his friends.
Jun 15, 2014 Issue
Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians screen adults 18 years or older for alcohol misuse and provide persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce alcohol misuse.
Detoxification is just “the tip of the iceberg,” and the postdischarge treatment program is key in determining whether patients will abstain from alcohol.
Approximately 2% to 9% of patients seen in a family physician’s office have alcohol dependence. These patients are at risk of developing alcohol withdrawal syndrome if they abruptly abstain from alcohol use. Alcohol withdrawal syndrome begins six to 24 hours after the last intake of alcohol, and the...
Nov 1, 2011 Issue
Opioid Antagonists for the Treatment of Alcohol Dependence [Cochrane for Clinicians]
Although it does not improve overall alcohol abstinence rates, the oral formulation of the opioid antagonist naltrexone (Revia) is moderately effective in decreasing the amount and frequency of alcohol consumption in patients with alcohol dependence.
Mar 1, 2011 Issue
Effectiveness of Acamprosate in the Treatment of Alcohol Dependence [Cochrane for Clinicians]
When used in conjunction with detoxification and psychosocial interventions for treating alcohol dependence, acamprosate can reduce the risk of any return to drinking and improve cumulative abstinence rates.
AWS may be managed with outpatient therapy if the patient has mild to moderate symptoms.